FDA’s regulation of generics, clinical trials being analyzed by OIG
Areas like generic drug regulation, drug supply chain and clinical trials reporting may be in need of some revamping by the Food and Drug Administration, according to a new Work Plan from the U.S. Department of Health and Human Services’ Office of the Inspector General. All items will be examined by the end of next year. Alexander […]